How Much Does Crestor (Rosuvastatin) Cost in Georgia in 2026?

Brand vs. Generic Pricing in Georgia

Generic rosuvastatin costs roughly $15 per month at most Georgia retail pharmacies in 2026. Brand-name Crestor, still manufactured by AstraZeneca, lists at approximately $290 per month. That gap matters.

The patent exclusivity for Crestor expired in 2016, and multiple generic manufacturers now produce rosuvastatin calcium tablets in 5 mg, 10 mg, 20 mg, and 40 mg strengths. According to the FDA's Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book), all rated-AB generics are considered therapeutically equivalent to the brand. Georgia pharmacists can substitute an AB-rated generic unless the prescriber writes "brand medically necessary" on the prescription.

The price spread between brand and generic has widened since 2020. Generic competition drove per-tablet costs below $0.50 at high-volume chains. Costco, Publix, and Kroger pharmacies across metro Atlanta, Savannah, and Augusta frequently price 30-day supplies of rosuvastatin 10 mg between $10 and $18 without insurance. Walmart's $4 generic list does not include rosuvastatin, but its cash price still falls under $20 in most Georgia locations.

For patients whose prescribers insist on brand Crestor, AstraZeneca's savings card can reduce out-of-pocket costs, though eligibility rules exclude government-insured patients (Medicaid, Medicare, Tricare). The savings card typically caps monthly copays at $3 for commercially insured patients, but terms change annually and patients should verify current offers directly through AstraZeneca's website.

Georgia Medicaid and Rosuvastatin Coverage

Georgia Medicaid covers rosuvastatin only under a type 2 diabetes indication, not for primary ASCVD prevention or isolated hyperlipidemia. This restriction creates a coverage gap for a significant number of Georgians.

The Georgia Department of Community Health administers Medicaid pharmacy benefits through its preferred drug list (PDL). Statins as a class are covered, but Crestor and its generics carry a prior authorization requirement that ties approval to a diabetes diagnosis. Patients prescribed rosuvastatin solely for LDL lowering or cardiovascular risk reduction may face a denial unless they also carry a T2D diagnosis code.

This matters clinically because the JUPITER trial (N=17,802) demonstrated that rosuvastatin 20 mg reduced major cardiovascular events by 44% in patients with elevated high-sensitivity C-reactive protein (hsCRP) but no diabetes and LDL cholesterol below 130 mg/dL. The trial was stopped early at a median follow-up of 1.9 years because the benefit was so pronounced [1]. Georgia Medicaid's restriction effectively locks out this exact patient population from the specific statin studied in that trial.

Alternatives for Medicaid patients who do not qualify include atorvastatin (generic Lipitor), which sits on Georgia's PDL as a preferred agent without the diabetes restriction. The 2018 AHA/ACC Cholesterol Guideline considers both rosuvastatin 20-40 mg and atorvastatin 40-80 mg as "high-intensity" statin therapy, so switching is clinically reasonable for most patients [2]. Prescribers should document the clinical rationale if filing a prior authorization appeal for rosuvastatin in a non-diabetic Medicaid patient.

Private Insurance Coverage Across Georgia

Most commercial plans in Georgia cover generic rosuvastatin on a preferred tier with copays ranging from $5 to $25 per month. Brand Crestor usually sits on a non-preferred or specialty tier, if covered at all.

Blue Cross Blue Shield of Georgia, Ambetter (managed by Centene subsidiary Peach State Health Plan), Kaiser Permanente of Georgia, Aetna, Cigna, and UnitedHealthcare all maintain formularies that include generic rosuvastatin. Tier placement varies by plan, but the generic typically lands on Tier 1 or Tier 2. Patients enrolled in high-deductible health plans (HDHPs) may pay the full cash price until their deductible is met, making the $15 average cash price a reasonable out-of-pocket baseline.

Medicare Part D plans in Georgia generally cover generic rosuvastatin with modest copays during the initial coverage phase. Under the Inflation Reduction Act's $2,000 annual out-of-pocket cap that took full effect in 2025, statin costs for Medicare beneficiaries are now more predictable. Rosuvastatin's low monthly cost means it rarely contributes meaningfully to reaching that cap, but the protection matters for patients on multiple medications.

Patients who are between plans or uninsured can use pharmacy discount programs. GoodRx, RxSaver, and SingleCare routinely show Georgia prices for rosuvastatin 10 mg at $8 to $15 for a 30-day supply. These discount card prices are not insurance and cannot be combined with insurance copays, but they often beat the uninsured cash price.

Compounded Rosuvastatin in Georgia: Legal Status and Availability

Compounded rosuvastatin is legal in Georgia through 503A-licensed compounding pharmacies. These pharmacies operate under patient-specific prescriptions and state board of pharmacy oversight.

Section 503A of the Federal Food, Drug, and Cosmetic Act permits state-licensed pharmacies to compound medications in response to a valid prescription for an individual patient. Georgia's composite medical board and board of pharmacy regulations align with this federal framework. A compounding pharmacy in Georgia can prepare rosuvastatin in alternative dosage forms (suspensions for patients who cannot swallow tablets, custom-strength capsules) as long as the prescription originates from a licensed prescriber and the pharmacy holds appropriate state licensure.

The practical reasons a patient might seek compounded rosuvastatin include dysphagia, pediatric dosing needs, or allergy to an inactive ingredient in commercial tablets (such as specific dyes or lactose). The FDA's compounding page notes that compounded drugs are not FDA-approved and do not undergo the same testing for safety, effectiveness, and quality as approved drugs [3].

Pricing for compounded rosuvastatin varies by pharmacy. Some 503A pharmacies in the Atlanta metro area advertise compounded statin preparations at low or no cost as part of membership-based pharmacy models. Patients should confirm that their compounding pharmacy is registered with the Georgia Board of Pharmacy and meets USP 795 standards for non-sterile compounding.

503B outsourcing facilities (which can distribute compounded drugs without patient-specific prescriptions) are a separate category. Georgia patients receiving rosuvastatin from a 503B facility should verify the facility's FDA registration status.

Telehealth Prescribing of Rosuvastatin in Georgia

Georgia permits telehealth prescribing of rosuvastatin. Patients can receive a prescription from a licensed provider via video or audio visit without an in-person exam.

Georgia's telehealth parity laws, updated through SB 167 (signed 2021), require that private insurers cover telehealth services at the same reimbursement rate as in-person visits. This means a telehealth consultation resulting in a rosuvastatin prescription is covered the same way an office visit would be.

For patients in rural Georgia counties where specialist access is limited, telehealth removes a barrier. A patient in Bainbridge or Waycross can consult a lipidologist in Atlanta, receive a prescription, and fill it at their local pharmacy. The prescriber must hold a valid Georgia medical license or practice under the Interstate Medical Licensure Compact, which Georgia joined.

A standard telehealth workflow for statin initiation involves reviewing recent lipid panel results (total cholesterol, LDL-C, HDL-C, triglycerides), assessing cardiovascular risk using the Pooled Cohort Equations recommended by the AHA/ACC, and discussing lifestyle modifications alongside pharmacotherapy [2]. The prescriber enters rosuvastatin into the e-prescribing system, and the patient picks up at any Georgia pharmacy.

Follow-up labs (fasting lipid panel, hepatic transaminases) are typically ordered 4 to 12 weeks after initiation per ACC/AHA guidelines [2]. These labs can be drawn at any Quest Diagnostics, Labcorp, or hospital lab in Georgia and reviewed at the next telehealth visit.

How to Get the Lowest Price on Rosuvastatin in Georgia

The cheapest path to rosuvastatin in Georgia combines a generic prescription with either insurance Tier 1 coverage or a pharmacy discount card. Total monthly cost: $5 to $18 in most cases.

Here is a practical decision tree:

Step 1: Confirm your prescriber writes for generic rosuvastatin, not brand Crestor. This single step saves $270 or more per month.

Step 2: Check your insurance formulary. If rosuvastatin sits on Tier 1, your copay is likely $5 to $15. If it sits on Tier 2, expect $15 to $25. If your plan does not cover rosuvastatin or you are in the deductible phase, move to Step 3.

Step 3: Compare discount card prices at nearby pharmacies. GoodRx, RxSaver, and Cost Plus Drugs (Mark Cuban's pharmacy) each show Georgia-specific pricing. Cost Plus Drugs ships nationally and prices rosuvastatin at its acquisition cost plus a flat markup and dispensing fee, often beating local retail prices.

Step 4: Consider 90-day fills. Many Georgia pharmacies and mail-order services offer 90-day supplies at a reduced per-unit cost. A 90-day supply of rosuvastatin 10 mg may cost $20 to $35, compared with $15 per month for three separate 30-day fills ($45 total).

Step 5: For Medicaid patients denied coverage, ask the prescriber to file a prior authorization citing a T2D diagnosis if applicable, or switch to atorvastatin, which is preferred on the Georgia PDL without restriction.

The NICE Technology Appraisal 94 and multiple cost-effectiveness analyses have shown that generic statins are among the most cost-effective preventive medications in cardiovascular medicine, with an incremental cost-effectiveness ratio well below $10,000 per quality-adjusted life year [4]. At $15 per month for a drug shown to reduce LDL cholesterol by 45% to 55% at the 10 mg dose, rosuvastatin represents strong value.

Clinical Context: Why Rosuvastatin Dose and Monitoring Matter

Rosuvastatin is the most potent statin per milligram. A 10 mg dose produces LDL reductions comparable to atorvastatin 40 mg to 80 mg, which shapes both clinical choices and insurance tier dynamics.

The Crestor prescribing information shows that rosuvastatin 5 mg reduces LDL-C by approximately 45%, 10 mg by 52%, 20 mg by 55%, and 40 mg by 63% from baseline [5]. The 40 mg dose carries additional monitoring requirements: the FDA label recommends checking creatine kinase (CK) levels in patients reporting muscle symptoms, and the 40 mg dose is contraindicated in patients of Asian descent without prior titration from lower doses due to higher systemic exposure.

In the JUPITER trial, rosuvastatin 20 mg reduced LDL-C by a median of 50% and hsCRP by 37% [1]. Dr. Paul Ridker, the trial's principal investigator, stated: "The findings suggest that among persons without hyperlipidemia but with elevated hsCRP, rosuvastatin significantly reduced the incidence of major cardiovascular events" [1].

The 2018 AHA/ACC Guideline on the Management of Blood Cholesterol classifies rosuvastatin 20-40 mg as high-intensity statin therapy and rosuvastatin 5-10 mg as moderate-intensity [2]. Guideline-directed prescribing matches intensity to the patient's risk category:

• High-intensity (rosuvastatin 20-40 mg): clinical ASCVD, LDL-C 190 mg/dL or higher, diabetes with multiple risk factors, or 10-year ASCVD risk of 20% or greater.
• Moderate-intensity (rosuvastatin 5-10 mg): diabetes without additional risk factors, 10-year ASCVD risk of 7.5% to 19.9%, or LDL-C 70-189 mg/dL with risk enhancers.

Baseline labs before starting rosuvastatin should include a fasting lipid panel, hepatic transaminases (ALT), hemoglobin A1c (statins slightly increase diabetes risk), and CK if the patient has a history of muscle disease. The FDA's post-marketing safety review added a warning about reversible cognitive effects and a small increased risk of diabetes with all statins, including rosuvastatin [6].

Follow-up lipid panels at 4 to 12 weeks confirm therapeutic response. If LDL-C reduction is less than expected, adherence assessment comes first. True pharmacologic non-response is rare with rosuvastatin given its high bioavailability (approximately 20%) and long half-life (19 hours).

Georgia-Specific Considerations for 2026

Georgia expanded Medicaid eligibility through a limited Section 1115 waiver program (Pathways to Coverage), not through full Medicaid expansion under the ACA. This means income eligibility thresholds remain lower than in full-expansion states, and the pharmacy benefit restrictions (including the rosuvastatin/T2D limitation) affect a population that has fewer alternative coverage options.

According to Kaiser Family Foundation state data, Georgia's uninsured rate was approximately 12.4% in 2024, the fifth highest in the nation [7]. For the estimated 1.3 million uninsured Georgians, generic rosuvastatin's $15 monthly price point is accessible relative to many chronic disease medications, but the cost of the prescribing visit itself may be the larger barrier. Federally Qualified Health Centers (FQHCs) in Georgia, which number over 200 sites, offer sliding-fee-scale visits and can prescribe rosuvastatin with onsite dispensing or 340B-discounted pricing.

The Georgia Board of Pharmacy permits pharmacists to engage in collaborative practice agreements (CPAs) with physicians, potentially allowing pharmacist-managed statin therapy in some clinical settings. This model, endorsed by the CDC's Community Preventive Services Task Force, has shown improved medication adherence and lipid goal attainment in other states [8].

Dr. Laurence Sperling, Director of Preventive Cardiology at Emory University, has noted: "Georgia has significant geographic disparities in cardiovascular care. Ensuring access to guideline-directed statin therapy, including affordable rosuvastatin, is a public health priority for rural counties where heart disease mortality rates exceed the national average" [9].

Patients filling rosuvastatin prescriptions at Georgia pharmacies should verify that their tablet strength matches the prescribed dose, store tablets at room temperature (68°F to 77°F), and take the medication at the same time daily. Rosuvastatin can be taken with or without food, and unlike some statins, it does not require evening dosing because of its long half-life.